Bellicum制药(BLCM)

王伟CFA美股MCORLEO2015-01-14 02:57

清了$Bellicum Pharmaceuticals (BLCM)$ 留着$ Juno Therapeutics (JUNO)$ //@MCorleone:清三分之一$ Juno Therapeutics (JUNO)$ ,清一半$Bellicum Pharmaceuticals (BLCM)$查看全文

chaseslime2015-01-13 22:29

回复@chaseslime: $Bellicum Pharmaceuticals (BLCM)$ $BLCM: Bellicum Pharmaceuticals announces successful dosing of first patient cohort with BPX-501 T Cells following haplo-identical hematopoietic stem cell transplant (31.33)
//@chaseslime:回复@chaseslime:$Bellicum Pharmace...查看全文

chaseslime2015-01-13 21:03

$Bellicum Pharmaceuticals (BLCM)$ Citigroup initiated Bellicum Pharmaceuticals (BLCM) coverage with Buy and target $36查看全文

维克多黄2015-01-12 23:48

我刚刚关注了 $Bellicum Pharmaceuticals (BLCM)$ ，当前价 31.32。查看全文

王伟CFA美股MCORLEO2015-01-12 22:36

我为什么要清啊 这俩药股真是一股都不应该卖啊。$ Juno Therapeutics (JUNO)$ 捂到100，$Bellicum Pharmaceuticals (BLCM)$ 捂到59。//@MCorleone:清三分之一$ Juno Therapeutics (JUNO)$ ,清一半$Bellicum Pharmaceuticals (BLCM)$查看全文

岁月是值得怀念的2015-01-12 22:35

$Bellicum Pharmaceuticals (BLCM)$和FMI一样被收了吧！10利润到手，继续看好，35不见不散！查看全文

chaseslime2015-01-12 21:26

$Bellicum Pharmaceuticals (BLCM)$ Piper Jaffray initiated Bellicum Pharmaceuticals (BLCM) coverage with Overweight and target $45
也是醉了。@MCorleone @股市之猪老白ISIG查看全文

淮山2015-01-10 14:32

$Bellicum Pharmaceuticals (BLCM)$ 咳…25·5进的 跌的时候不敢加仓 涨到26就卖了 现在看起来真亏 各位大神们给个建议我该现在进货呢还是等等看回调呢？查看全文

爱乐高2015-01-10 07:12

$Bellicum Pharmaceuticals (BLCM)$ 这股还能入吗？查看全文

王伟CFA美股MCORLEO2015-01-10 02:05

清三分之一$ Juno Therapeutics (JUNO)$ ,清一半$Bellicum Pharmaceuticals (BLCM)$查看全文

超过5%股东持股披露「修订」

$Bellicum制药(BLCM)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-120984  Act: 34  Size: 219 KB 网页链接

持股变动声明

$Bellicum制药(BLCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-056578  Size: 22 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001628280-23-039830  Act: 34  Size: 808 KB 网页链接

季度财报

$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-038953  Act: 34  Size: 4 MB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001628280-23-033257  Act: 34  Size: 199 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 7.01 Accession Number: 0001628280-23-030016  Act: 34  Size: 186 KB 网页链接

季度财报

$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-028893  Act: 34  Size: 4 MB 网页链接

其他

$Bellicum制药(BLCM)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000485  Act: 34  Size: 3 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 5.02 Accession Number: 0001628280-23-020619  Act: 34  Size: 197 KB 网页链接

当期报告

$Bellicum制药(BLCM)$ 8-K Current report, item 3.01 Accession Number: 0001628280-23-020109  Act: 34  Size: 198 KB 网页链接